Figure 3
Disease free survival (DFS) for patients with stage IIIC1 (FIGO 2018) regarding number of pelvic lymph node metastasis. 3y-DFS: ≥2 vs <2 = 55.8% vs 79.6% (HR = 2.10, 95%CI = 1.04–4.24, P = 0.039).
Figure 3 | Scientific Reports
Disease free survival (DFS) for patients with stage IIIC1 (FIGO 2018) regarding number of pelvic lymph node metastasis. 3y-DFS: ≥2 vs <2 = 55.8% vs 79.6% (HR = 2.10, 95%CI = 1.04–4.24, P = 0.039).
